SPDR S&P Biotech ETF | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (73)

Latest Posts

About This Stock More About This Stock
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Article By: Rod Raynovich
Tuesday, April 16, 2024 2:05 AM EDT
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
In this article: ABT, JNJ, LLY, MRK, NVO, UNH, IBB, XBI, XLV
Read
Healthcare And Biotech Stocks Review: Q1 2024 Performance
Article By: Rod Raynovich
Monday, April 1, 2024 4:07 AM EDT
We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight trend toward more balanced performance.
In this article: PFE, UNH Also: IBB, XBI, XLE, XLK, XLV
Read
2 Top Biotech Buyout Candidates
Article By: Andrew Rocco
Sunday, March 31, 2024 4:00 PM EDT
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be bought out. Here are some top buyout candidates.
In this article: VKTX, MDGL Also: LLY, NVO, IBB, XBI
Read
AskSlim Market Week - Friday, March 28
Video By: Steve Miller
Thursday, March 28, 2024 2:36 PM EDT
An analysis and commentary on the financial markets.
In this video: COPX, FCX, SPY, XBI
Watch
Biotechnology And Healthcare, A Bit Of A Lull
Article By: Rod Raynovich
Monday, March 25, 2024 7:00 PM EDT
Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.
In this article: LLY, IBB, XBI, XLV, SUPN, ABBV
Read

Latest Tweets for $XBI

No tweets yet!

PARTNER HEADLINES

$XBI

Biotech Review - Waiting For A Reset
Dick Kaplan 2/23/2021 5:25:18 PM

Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.

Leadership (Bio-Tech) Breakout; Good Sign For Broad Market
Abe Jouejati 3/1/2017 4:46:32 PM

My Simple Forecast:

Looks like $XBI has had a positive growth trend. With middle of the year approaching I believe that the cycle will repeat, thus hitting high points again. The seasonal patterns may be based on the rate of discovery of new technology, so cycles may be of unusual lengths. Nonetheless, looks like $XBI is positively correlated to SP500, and it is leading variable. We can anticipate new highs by beginning Q3.

1 to 2 of 2 comments